Sparsentan: Sparsentan- A novel, non- immunosuppressive, dual action angiotensin II and endothelin A receptor antagonist -A new hope for glomerular disease. J Shaheed Suhrawardy Med Coll. 2024;14(2):58-62. doi:10.3329/jssmc.v14i2.73180